Filing Details
- Accession Number:
- 0001140361-16-054824
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-25 14:27:52
- Reporting Period:
- 2016-02-17
- Filing Date:
- 2016-02-25
- Accepted Time:
- 2016-02-25 14:27:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1094176 | Anne M Szostak | One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-02-17 | 2,000 | $69.94 | 8,816 | No | 4 | P | Indirect | M. Anne Szostak Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | M. Anne Szostak Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 584 | Direct | |
Common Stock | 6,600 | Indirect | 2014 Szostak IDEXX GRAT |
Footnotes
- The purchase price reported reflects the weighted average purchase price of multiple transactions on the reported date at prices that ranged from $69.890 to $69.980, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.